🇫🇷 France Country × Condition
systemic lupus erythematosus Clinical Trials in France
Active clinical trials for systemic lupus erythematosus with research sites in France. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 5 // Recruiting: 5 Phases: Phase 1 // Updated: Daily
Total Trials
5
Recruiting Now
5
Country
🇫🇷 France
Active Trials in France (5)
NCT07260942
Recruiting
Ferroptosis Role in the Pathophysiology of Systemic Lupus Erythematosus
Enrollment
120 pts
Country
🇫🇷 France
University Hospital, Bordeaux
View Trial → NCT07371468 Phase 1
Recruiting
A Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
Enrollment
44 pts
Country
🇫🇷 France
GlaxoSmithKline
View Trial → NCT06551389
Recruiting
Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU
Enrollment
300 pts
Country
🇫🇷 France
University Hospital, Brest
View Trial → NCT06593041
Recruiting
ROLE of PLATELETS in the PATHOPHYSIOLOGY of SYSTEMIC LUPUS
Enrollment
450 pts
Country
🇫🇷 France
University Hospital, Strasbourg, Fr...
View Trial → NCT07251179
Recruiting
Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies
Enrollment
200 pts
Country
🇫🇷 France
University Hospital, Strasbourg, Fr...
View Trial → Frequently Asked Questions
How many systemic lupus erythematosus clinical trials are active in France?
There are currently 5 active clinical trials for systemic lupus erythematosus with sites in France, of which 5 are actively recruiting patients.
How can I join a systemic lupus erythematosus clinical trial in France?
To join a systemic lupus erythematosus clinical trial in France, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in France directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are systemic lupus erythematosus trials in France?
Active systemic lupus erythematosus trials in France span Phase 1. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology